Clearance brings full cerebral and systemic embolic protection to patients undergoing transcatheter aortic valve replacement (TAVR)
LONDON, Sept. 9, 2026 /PRNewswire/ — Full-Life Technologies (“Full-Life”, the “Company”), a privately held, fully integrated, clinical-stage actinium-based global radiopharmaceutical company, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for [225Ac]Ac-FL-261 and that the program has received Australian Human Research Ethics Committee (“HREC”) approval and completed the Clinical Trial Notification (“CTN”) process with Therapeutic Goods Administration (“TGA”).
This registration marks the Company’s second product authorized in Europe and its first expansion beyond prenatal care into the broader women’s health market
Danish medtech company Ropca will bring its autonomous musculoskeletal ultrasound system to the U.S. after receiving FDA 510(k) clearance
WashU Medicine researchers led by Jacco Boon, a professor in the John T. Milliken Department of Medicine, report that an experimental bird flu vaccine provides strong immune protection in mice, including in animals previously vaccinated against seasonal flu. Because pre-existing immunity from prior seasonal influenza infection or vaccination could diminish the efficacy of H5N1 vaccines, showing that the new vaccine succeeds alongside existing immunity is a crucial milestone.
An international research team led by Dr. Lucia Torres Fernández from the working groups of Professor Dr. Julie George and Professor Dr. Roman Thomas at the University of Cologne has identified a critical dependency in small cell lung cancer (SCLC) that can be exploited therapeutically.
A team of UTHealth Houston researchers slowed and even reversed diabetic nerve damage in mice, bringing researchers one step closer to developing a treatment for humans. The research is published in Science Translational Medicine.
A University of Minnesota–led multi-institutional research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus’s entry protein and provides strong protection when given orally in a preclinical model.
A nasal spray containing vesicles naturally released by cells may work against Alzheimer’s. This is the promise of a study conducted by researchers at the Università Cattolica, Fondazione Policlinico Universitario A. Gemelli IRCCS, and the E. Menni Research Center of Fondazione Poliambulanza.
The brain is a black box of densely packed neurons, blood vessels and immune cells, all locked away in a sealed skull. WashU’s Song Hu has dedicated his career to unlocking that puzzle box by developing new ways to “see” inside. His team’s newest innovation could give researchers a new view of how brain cells and blood vessels work together and what happens when the coupling between the two breaks down.